Pfizer Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
FY2008
Asset Breakdown FY2024
Total Assets: $213.40B
Liabilities Breakdown FY2024
Total Liabilities: $124.90B
Asset Breakdown
Total Assets: $213.40B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.04B | 0.5% |
| Accounts Receivable | $11.46B | 5.4% |
| Inventory | $10.85B | 5.1% |
| Property, Plant & Equipment | $18.39B | 8.6% |
| Goodwill | $68.53B | 32.1% |
| Intangible Assets | $55.41B | 26.0% |
| Other Assets | $47.71B | 22.4% |
Liabilities Breakdown
Total Liabilities: $124.90B
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $5.63B | 4.5% |
| Long-Term Debt | $57.41B | 46.0% |
| Other Liabilities | $61.86B | 49.5% |